Hinge Health, Inc. (NYSE: HNGE) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $9.3B. The Maz Rating grades it against the other companies in its sector.
Hinge Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $114.74, Hinge Health, Inc. trades at 58.3x trailing earnings, 12.3x sales and 32.8x book value, with an EV/EBITDA of 58.9. Over the last twelve months it generated about $758M of revenue and $160M of net income. It runs a gross margin of 85.7%, an operating margin of 18.7% and a net margin of 21.0%. It shows return on equity of 50.5%, return on invested capital of 44.9% and a free cash flow yield of 3.2%. On the balance sheet: a debt-to-equity ratio of 0.11 and a current ratio of 1.04. Over the past 52 weeks the share price ranged from $30.08 to $126.40, with a beta of 1.36.
Hinge Health, Inc. does not currently pay a dividend.
17 Wall Street analyst ratings cover the stock: 16 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.